Latest News & Features
Americas
The US Food and Drug Administration has approved a biosimilar version of Janssen Biotech’s drug Remicade. 6 April 2016
Americas
Pharmaceutical company Millennium Pharmaceuticals has sued Actavis, accusing it of infringing a patent covering a drug used to treat myeloma and mantle cell lymphoma. 5 April 2016
Asia
Law firm Foley & Lardner has expanded its intellectual property department and its chemical, biotechnology and pharmaceutical practice by hiring Philippe Riesen as a partner. 5 April 2016
Americas
The Federal Trade Commission has sued Endo Pharmaceuticals for allegedly violating competition laws by agreeing to so-called pay-for-delay settlements surrounding the launch of generic versions of two drugs. 4 April 2016
Africa
Pharmaceutical company GSK has adopted a new approach to patents and intellectual property to widen access to medicines in the world’s poorest countries. 1 April 2016
Big Pharma
Owners of second medical use patents may need to think outside the box in terms of the relief they seek for infringement, says Katie Hutchinson of Bristows. 31 March 2016
Asia
India-based pharmaceutical company Sun Pharmaceutical has acquired 14 prescription brands from Novartis in Japan for $293 million. 31 March 2016
Americas
Law firm Reed Smith has hired Nicolas Barzoukas and Josh Davis as partners in the firm’s intellectual property, information and innovation practice group in Houston. 31 March 2016
Americas
No patent application directed to CRISPR has yet fallen foul of the EU’s Biotech Directive on the basis of the human embryo use exception, but the technology is still in its nascent stage. Ashley Roughton of Nabarro reports. 31 March 2016
Americas
US presidential hopeful Bernie Sanders has urged the government to hold a hearing to determine whether a patent covering a prostate cancer drug should be licensed in a bid to lower its price. 30 March 2016